Peptide Synthesizers & Custom Synthesis
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
737
NCT02547818
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Phase: Phase 3
Role: Collaborator
Start: Sep 15, 2015
Completion: Nov 18, 2020
NCT06582277
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836
Phase: Phase 2
Start: Oct 22, 2024
Completion: Jun 2, 2025
Loading map...